CNTB
Price
$2.26
Change
-$0.25 (-9.96%)
Updated
Jul 13 closing price
Capitalization
142.3M
63 days until earnings call
Intraday BUY SELL Signals
PHVS
Price
$35.07
Change
-$0.00 (-0.00%)
Updated
Jul 13 closing price
Capitalization
2.45B
36 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTB vs PHVS

CNTB vs PHVS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CNTB vs. PHVS commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTB is a Buy and PHVS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (CNTB: $2.26 vs. PHVS: $35.07)
Brand notoriety: CNTB and PHVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTB: 75% vs. PHVS: 42%
Market capitalization -- CNTB: $142.3M vs. PHVS: $2.45B
CNTB [@Biotechnology] is valued at $142.3M. PHVS’s [@Biotechnology] market capitalization is $2.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTB’s FA Score shows that 0 FA rating(s) are green whilePHVS’s FA Score has 0 green FA rating(s).

  • CNTB’s FA Score: 0 green, 5 red.
  • PHVS’s FA Score: 0 green, 5 red.
According to our system of comparison, PHVS is a better buy in the long-term than CNTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTB’s TA Score shows that 4 TA indicator(s) are bullish while PHVS’s TA Score has 3 bullish TA indicator(s).

  • CNTB’s TA Score: 4 bullish, 6 bearish.
  • PHVS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PHVS is a better buy in the short-term than CNTB.

Price Growth

CNTB (@Biotechnology) experienced а -4.24% price change this week, while PHVS (@Biotechnology) price change was +5.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

CNTB is expected to report earnings on Sep 15, 2026.

PHVS is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHVS($2.45B) has a higher market cap than CNTB($142M). PHVS YTD gains are higher at: 26.378 vs. CNTB (-19.858). CNTB has higher annual earnings (EBITDA): -65.54M vs. PHVS (-171.49M). PHVS has more cash in the bank: 247M vs. CNTB (46M). CNTB has less debt than PHVS: CNTB (693K) vs PHVS (739K). CNTB has higher revenues than PHVS: CNTB (233K) vs PHVS (0).
CNTBPHVSCNTB / PHVS
Capitalization142M2.45B6%
EBITDA-65.54M-171.49M38%
Gain YTD-19.85826.378-75%
P/E RatioN/AN/A-
Revenue233K0-
Total Cash46M247M19%
Total Debt693K739K94%
TECHNICAL ANALYSIS
Technical Analysis
CNTBPHVS
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 12 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CNTB
Daily Signal:
Gain/Loss:
PHVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JVAIX41.07N/A
N/A
JPMorgan Value Advantage L
FMFEX98.32N/A
N/A
Fidelity Advisor Materials I
TCMSX55.98N/A
N/A
Voya Small Cap Growth I
LEQIX11.92N/A
N/A
LoCorr Dynamic Opportunity I
RMBKX62.85N/A
N/A
RMB Mendon Financial Services A

PHVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHVS has been loosely correlated with INKT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PHVS jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHVS
1D Price
Change %
PHVS100%
N/A
INKT - PHVS
40%
Loosely correlated
+0.90%
KYTX - PHVS
35%
Loosely correlated
-8.43%
SVRA - PHVS
33%
Loosely correlated
-4.81%
MGTX - PHVS
31%
Poorly correlated
-7.84%
BEAM - PHVS
31%
Poorly correlated
-5.14%
More